These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
493 related items for PubMed ID: 10538456
1. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy. Ettinger B, Pressman A. Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456 [Abstract] [Full Text] [Related]
2. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen. Ettinger B, Pressman A, Bradley C. Menopause; 1998 Jun; 5(3):152-6. PubMed ID: 9774760 [Abstract] [Full Text] [Related]
3. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women. Ichikawa J, Sumino H, Ichikawa S, Ozaki M. Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131 [Abstract] [Full Text] [Related]
4. Effects of postmenopausal hormone replacement therapy on body fat composition. Yüksel H, Odabasi AR, Demircan S, Köseoğlu K, Kizilkaya K, Onur E. Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160 [Abstract] [Full Text] [Related]
5. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins. Vrablik M, Fait T, Kovar J, Poledne R, Ceska R. Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386 [Abstract] [Full Text] [Related]
8. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance. Erenus M, Karakoç B, Gürler A. Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947 [Abstract] [Full Text] [Related]
10. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate. Castelo-Branco C, Casals E, Sanllehy C, Duran M, Fortuny A, Vanrell JA. J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134 [Abstract] [Full Text] [Related]
11. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women. Ho JY, Chen MJ, Sheu WH, Yi YC, Tsai AC, Guu HF, Ho ES. Hum Reprod; 2006 Oct; 21(10):2715-20. PubMed ID: 16807281 [Abstract] [Full Text] [Related]
12. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels. Chiantera V, Sarti CD, Fornaro F, Farzati A, De Franciscis P, Sepe E, Borrelli AL, Colacurci N. Menopause; 2003 Oct; 10(4):286-91. PubMed ID: 12851511 [Abstract] [Full Text] [Related]
13. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT. Serrano D, Mariani L, Mora S, Guerrieri-Gonzaga A, Cazzaniga M, Daldoss C, Ramazzotto F, Feroce I, Decensi A, Bonanni B. Maturitas; 2006 Aug 20; 55(1):69-75. PubMed ID: 16500052 [Abstract] [Full Text] [Related]
15. The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis. Eilertsen AL, Høibraaten E, Os I, Andersen TO, Sandvik L, Sandset PM. Maturitas; 2005 Oct 16; 52(2):111-8. PubMed ID: 16186073 [Abstract] [Full Text] [Related]
17. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus. Araújo DA, Farias ML, Andrade AT. Climacteric; 2002 Sep 16; 5(3):286-92. PubMed ID: 12419087 [Abstract] [Full Text] [Related]